Why we should take care of the competing risk bias in survival analysis: a phase II trial on the toxicity profile of radiotherapy for prostate cancer

ConclusionsThis study confirms that using inappropriate statistical methods produces a 10% overestimation in results, as described in the literature, and highlights the importance of taking into account the competing risks bias.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research